Pacer Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Pacer Advisors’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,062	Closed	-$78K	–	1618
2021 Q1	$78K	Buy	2,062 +1,164	+130%	+$29K	﹤0.01%	1329
2020 Q4	$15K	Buy	+898	New	+$11.3K	﹤0.01%	1494
2018 Q4	–	Sell	-3,112	Closed	-$43K	–	1137
2018 Q3	$43K	Buy	+3,112	New	+$46.3K	﹤0.01%	1151
2018 Q1	–	Sell	-607	Closed	-$13K	–	1160
2017 Q4	$13K	Buy	+607	New	+$19.5K	﹤0.01%	1131

Pacer Advisors's FPRX Position: Q2 2021 in Review

Pacer Advisors sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 2,062 shares — an estimated $78K sold.

Pacer Advisors first reported a position in FPRX in Q4 2017 and held it in 4 quarters. The position peaked at $78K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Pacer Advisors reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Pacer Advisors sold 2,062 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $78K.
Pacer Advisors first reported a position in Five Prime Therapeutics, Inc. in Q4 2017 and held it in 4 quarters.
Pacer Advisors's Five Prime Therapeutics, Inc. position peaked at $78K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.